References
- Tsujimoto, M., Kakei, Y., Yamano, N., Fujita, T., Ueda, T., Ono, R.,
Murakami, S., Moriwaki, S., & Nishigori, C. (2023). Clinical trial on
the efficacy and safety of NPC-15 for patients with xeroderma
pigmentosum exaggerated sunburn reaction type: XP-1 study protocol for
a multicentre, double-blinded, placebo-controlled, two-group crossover
study followed by a long-term open study in Japan. BMJ Open, 13(3),
e068112. https://doi.org/10.1136/bmjopen-2022-068112
- Searle, T., Walburn, J., & Norton, S. (2021). A randomised controlled
trial to investigate the effectiveness of sustained photoprotective
behaviour in xeroderma pigmentosum after intervention. BJPsych Open,
7(S1), S287. https://doi.org/10.1192/bjo.2021.764
- Karass, M., Naguib, M. M., Elawabdeh, N., Cundiff, C. A., Thomason,
J., Steelman, C. K., Cone, R., Schwenkter, A., Jordan, C., & Shehata,
B. M. (2014). Xeroderma Pigmentosa: Three New Cases with an In Depth
Review of the Genetic and Clinical Characteristics of the Disease.
Fetal and Pediatric Pathology, 34(2), 120–127.
https://doi.org/10.3109/15513815.2014.982336
- Priya, P. G. S. R., & Janaki, M. G. (2017). Carcinoma esophagus with
xeroderma pigmentosa. Journal of Cancer Research and Therapeutics,
14(2), 451–453. https://doi.org/10.4103/jcrt.jcrt_1264_16
- Matsumoto, M., Kaneshiro, K., & Takatsuki, K. (2021). Lung
adenocarcinoma concomitant with xeroderma pigmentosum: a case report.
Journal of Medical Case Reports, 15(1).
https://doi.org/10.1186/s13256-021-02754-0
- Sharma, S., Hashmi, M. F., & Chakraborty, R. K. (2020). StatPearls
[internet].
- Lucero, R., & Horowitz, D. (2023, July 4). Xeroderma Pigmentosum.
StatPearls - NCBI Bookshelf.
https://www.ncbi.nlm.nih.gov/books/NBK551563/
- Mamada, A., Miura, K., Tsunoda, K., Hirose, I., Furuya, M., & Kondo,
S. (1992). Xeroderma pigmentosum Variant Associated with Multiple Skin
Cancers and a Lung Cancer. Dermatology, 184(3), 177–181.
https://doi.org/10.1159/000247536
- Alzubaidi, A., Kaur, J., Mahmud, M., Brown, D. J., He, J., Ball, G.,
Baldwin, D. R., O’Dowd, E., & Hubbard, R. B. (2021). Selecting Lung
Cancer Patients from UK Primary Care Data: A Longitudinal Study of
Feature Trends. In Communications in computer and information science
(pp. 43–59). https://doi.org/10.1007/978-3-030-82269-9_4
- Hoffmann, M., Reitz, D., Taugner, J., Roengvoraphoj, O., Käsmann, L.,
Eze, C., Karin, M., Belka, C., & Manapov, F. (2020). Blood Parameters
Demonstrating a Significant Survival Impact in Patients With Locally
Advanced NSCLC Undergoing Definitive Chemoradiotherapy. Anticancer
Research, 40(4), 2319–2322. https://doi.org/10.21873/anticanres.14198
- Côté, E., & Micieli, J. A. (2020). Vertical One-and-a-Half Syndrome
Due to Metastatic Spindle Cell Carcinoma of the Lung. Canadian Journal
of Neurological Sciences / Journal Canadien Des Sciences
Neurologiques, 47(5), 685–686. https://doi.org/10.1017/cjn.2020.100
- Dillard, T. A., Patel, R. R., & Schroeder, C. (2015). Uneven
Distribution of Cancer Histology in the National Lung Screening Trial.
The American Journal of the Medical Sciences, 350(3), 219–221.
https://doi.org/10.1097/maj.0000000000000516
- DeWitt, J., Cho, C., Lin, J., Al-Haddad, M., Canto, M., Salamone, A.,
Hruban, R., Messallam, A., & Khashab, M. (2015). Comparison of
EUS-guided tissue acquisition using two different 19-gauge core biopsy
needles: a multicenter, prospective, randomized, and blinded study.
Endoscopy International Open, 03(05), E471–E478.
https://doi.org/10.1055/s-0034-1392222
- Liu, Q., Cai, W., Wang, X., Hu, H., Sun, X., Pan, X., & Wang, A.
(2023). Recent death early warning value of ECG changes in patients
with NSCLC. Medicine, 102(46), e35698.
https://doi.org/10.1097/md.0000000000035698
- Luo, M., Duan, C., Qiu, J., Li, W., Zhu, D., & Cai, W. (2015).
Diagnostic Value of Multidetector CT and Its Multiplanar Reformation,
Volume Rendering and Virtual Bronchoscopy Postprocessing Techniques
for Primary Trachea and Main Bronchus Tumors. PLoS ONE, 10(9),
e0137329. https://doi.org/10.1371/journal.pone.0137329
- Choi, J., Tocco, B., Smith, A., Ahmad, S., Josephides, E., & Bille,
A. (2023). Multimodality Treatment and Salvage Surgery for the
Treatment of Lung Cancer. Cancers , 15 (14), 3586.
https://doi.org/10.3390/cancers15143586
- Wieland, J., Hoppe, B. S., Rausch-Osian, S. M., King, J. C., Sierra,
A., Hiemenz, J. W., Bradley, J., Pham, D. C., Jones, L. M., Yeung, A.
R., Hopper, K., Mendenhall, N. P., & Hitchcock, K. E. (2019).
Survivor and Caregiver Expectations and Preferences Regarding Lung
Cancer Treatment. International Journal of Particle Therapy ,6 (2), 42–49. https://doi.org/10.14338/ijpt-19-00072.1
- Menis, J., & Reck, M. (2020). Checkpoint Inhibitors in SCLC: How Much
Can We Trust in Randomized Cohorts of Phase I/II Trials? Journal
of Thoracic Oncology , 15 (3), 308–310.
https://doi.org/10.1016/j.jtho.2019.11.031